MedPath
Found 29 clinical trials|View Analysis
Sort by:

Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

Phase 3
Not yet recruiting
Conditions
Gall Bladder Carcinoma
Interventions
Procedure: curative surgery
Drug: neoadjuvant chemotherapy
First Posted Date
2024-12-02
Last Posted Date
2024-12-02
Lead Sponsor
Rajiv Gandhi Cancer Institute & Research Center, India
Target Recruit Count
114
Registration Number
NCT06712420
Locations
🇮🇳

Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India

Predictors of One-Year Mortality After Curative Surgery in Patients Aged 80 Years or Older With Non-Metastatic Colorectal Cancer

Completed
Conditions
Colorectal Cancer
First Posted Date
2024-11-26
Last Posted Date
2024-11-27
Lead Sponsor
National Taiwan University Hospital
Target Recruit Count
310
Registration Number
NCT06704646

Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum

Recruiting
Conditions
Rectal Cancer
Interventions
Procedure: curative surgery for cancer rectum
First Posted Date
2023-10-23
Last Posted Date
2023-10-23
Lead Sponsor
South Valley University
Target Recruit Count
200
Registration Number
NCT06096493
Locations
🇪🇬

Qena Faculty of Medicine, South Valley University Hospitals, Qinā, Egypt

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

Phase 2
Recruiting
Conditions
Biliary Tract Cancer
Cholangiocarcinoma
Interventions
First Posted Date
2023-09-14
Last Posted Date
2023-11-15
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
300
Registration Number
NCT06037980
Locations
🇮🇹

Humanitas Cancer Center, Milan, Italy

🇮🇹

Azienda Ospedaliera Universitaria Pisa, Pisa, Italy

🇮🇹

ASST Spedali Civili, Brescia, Italy

and more 16 locations

A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery

Recruiting
Conditions
Gastric Cancer
Predictive Cancer Model
Hepatic Metastasis
First Posted Date
2023-09-05
Last Posted Date
2023-10-26
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
120
Registration Number
NCT06023966
Locations
🇨🇳

Cancer Hospital of Tianjin Medical University, Tianjin, 天津, China

VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

Completed
Conditions
Colon Cancer
Deep Vein Thrombosis, Pulmonary Embolus
First Posted Date
2023-08-24
Last Posted Date
2023-08-24
Lead Sponsor
Nordsjaellands Hospital
Target Recruit Count
2141
Registration Number
NCT06009484

PET on Surgery for Loco-regionally Recurrent Colorectal Cancer

Completed
Conditions
Loco-regional Recurrent Colorectal Cancer
PET-driven Surgery
Interventions
Procedure: Curative intent surgery
First Posted Date
2023-06-29
Last Posted Date
2023-07-05
Lead Sponsor
National Taiwan University Hospital
Target Recruit Count
193
Registration Number
NCT05924282
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

Pembrolizumab in Combination With Lenvatinib in Pts With Recurrent, Persistent, Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy

Phase 2
Not yet recruiting
Conditions
Recurrent Vulvar Cancer
Persistent Vulvar Cancer
Metastatic Vulva Cancer
Locally Advanced Vulvar Cancer
Interventions
First Posted Date
2023-06-15
Last Posted Date
2024-08-09
Lead Sponsor
AGO Research GmbH
Target Recruit Count
42
Registration Number
NCT05903833

ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

Recruiting
Conditions
Metastatic Colorectal Cancer
Circulating Tumor DNA
First Posted Date
2023-03-28
Last Posted Date
2024-02-05
Lead Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Target Recruit Count
232
Registration Number
NCT05787197
Locations
🇫🇷

CHU de Poitiers, Poitiers, France

🇫🇷

CHU Rouen, Rouen, France

🇫🇷

Hôpital Pitié Salpêtrière, Paris, France

and more 13 locations

Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer

Recruiting
Conditions
Colon Cancer Stage I
Colon Cancer
Interventions
Procedure: Colonic resection
First Posted Date
2023-02-13
Last Posted Date
2023-07-21
Lead Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Target Recruit Count
2000
Registration Number
NCT05726188
Locations
🇮🇹

Chirurgia Generale Colorettale, Ospedale degli Infermi, Faenza, Italy

🇮🇹

Chirurgia Generale 3, AOUI Padova, Padova, Italy

🇮🇹

UOC Chirurgia Generale 1, Policlinico Gemelli, Roma, Italy

and more 21 locations
© Copyright 2025. All Rights Reserved by MedPath